Richard Horton on the Oxford vaccine phase 3 trial episode artwork

EPISODE · Dec 8, 2020 · 11 MIN

Richard Horton on the Oxford vaccine phase 3 trial

from The Lancet in conversation with · host The Lancet

Editor-in-chief of The Lancet, Richard Horton, discusses the results of the Oxford vaccine's phase 3 trial. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

Editor-in-chief of The Lancet, Richard Horton, discusses the results of the Oxford vaccine's phase 3 trial. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

NOW PLAYING

Richard Horton on the Oxford vaccine phase 3 trial

0:00 11:32

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Lancet in conversation with?

This episode is 11 minutes long.

When was this The Lancet in conversation with episode published?

This episode was published on December 8, 2020.

What is this episode about?

Editor-in-chief of The Lancet, Richard Horton, discusses the results of the Oxford vaccine's phase 3 trial. Continue this conversation on social! Follow us today...

Can I download this The Lancet in conversation with episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!